Posted on

Cost of EpiPen: One Democrat senator’s daughter is Mylan CEO, another’s needs drug

Heather Bresch

“Then in February the FDA rejected Teva’s generic EpiPen application. In June the FDA required a San Diego-based company called Adamis to expand patient trials and reliability studies for still another auto-injector rival.

Mrs. Clinton claims the EpiPen price hikes show the need for price controls, and she says she’ll require drug makers to “prove that any additional costs are linked to additional patient benefits and better value.”

The government thwarts competition, and so a life-saving Epi-Pen costs $500 where it was just $100 in 2008. When you have a monopoly, you can charge anything you like. The solution is not government price controls, Hillary, but increased competition.

Alieta Eck, MD For Real Health Care Reform

 

By Eugene Scott, CNN
Updated 1:32 PM ET, Thu August 25, 2016

Washington (CNN)The incredible increase in the cost of EpiPens, auto-injectors that can stop life-threatening emergencies caused by allergic reactions, has hit home on Capitol Hill.

One Democratic senator whose daughter has allergies has called for action and another Democratic senator’s daughter is CEO of the company responsible for the price hike.

Sen. Joe Manchin said Thursday Mylan, the company which manufactures Epipens which is headed by his daughter, is responding to constituent and lawmaker questions.
“I am aware of the questions my colleagues and many parents are asking and frankly I share their concerns about the skyrocketing prices of prescription drugs,” the West Virginia Democrat said in a statement. “Today I heard Mylan’s initial response, and I am sure Mylan will have a more comprehensive and formal response to those questions‎.”
His daughter, Heather Bresch who is Mylan’s CEO, announced Thursday the company is taking steps to make the product more affordable, including providing $300 savings cards to cut the price in half, though she told CNBC the health care “system” needed to be fixed.

https://www.cnn.com/2016/08/24/politics/epipens-congress-response/